# Situation: A public health nurse at a Rural Health Unit (RHU) in an agricultural municipality sees clients referred by the barangay health workers (BHWs). A 45-year-old farmer has had a productive cough for 3 weeks with night sweats and weight loss. According to the National Tuberculosis Program (NTP), which initial diagnostic test should the nurse arrange?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=627011  
> language: ko  
> subject: Nursing Practice I — Community Health Nursing

## 문제

Situation: A public health nurse at a Rural Health Unit (RHU) in an agricultural municipality sees clients referred by the barangay health workers (BHWs).

A 45-year-old farmer has had a productive cough for 3 weeks with night sweats and weight loss. According to the National Tuberculosis Program (NTP), which initial diagnostic test should the nurse arrange?

## 보기

1. Sputum smear microscopy on two early-morning specimens
2. Tuberculin skin test read after 48 to 72 hours
3. Rapid molecular test (NAAT) on a sputum specimen **✔ 정답**
4. Chest X-ray alone, with sputum only if the film is abnormal

**정답: 3**

## 해설

The client is a presumptive TB case (cough of 2 weeks or more with other symptoms). The NTP uses a rapid molecular test (nucleic acid amplification test, NAAT) as the preferred initial test because it detects TB and rifampicin resistance at the same time. Smear microscopy is now used mainly to monitor treatment.

## 심화 해설

Clinical situation A 45-year-old farmer presents with a productive cough lasting 3 weeks, night sweats, and weight loss. This symptom combination meets the operational definition of a presumptive TB case: cough of 2 weeks or more plus at least one other suggestive symptom. In a rural agricultural setting served by an RHU, the nurse must select the initial diagnostic test that aligns with the National Tuberculosis Program (NTP) algorithm.

Why the rapid molecular test is the correct first step The NTP prioritizes a rapid molecular test, specifically a nucleic acid amplification test (NAAT), as the preferred initial diagnostic tool for presumptive pulmonary TB. The core advantage is that a single sputum specimen can simultaneously confirm the presence of Mycobacterium tuberculosis complex and detect rifampicin resistance, which is a key marker for multidrug-resistant TB (MDR-TB). This dual output allows the clinician to start an appropriate regimen immediately rather than waiting for culture-based drug susceptibility testing.

The evidence base supports this programmatic shift. Molecular platforms such as Xpert MTB/RIF are described as automated, cartridge-based NAATs that have changed the diagnostic landscape by moving TB detection closer to the point of care [2]. A review of WHO-endorsed NAATs notes that low- and moderate-complexity assays, including Xpert MTB/RIF, are now positioned for decentralized and near-patient testing, which is precisely the context of a Rural Health Unit [3]. The same review emphasizes that these assays detect both TB and drug resistance in a single run, reinforcing why smear microscopy alone is no longer the preferred initial test [3].

Why the other options are not the initial test of choice

| Option | Role in NTP algorithm | Why it is not the first-line initial test |
| --- | --- | --- |
| Sputum smear microscopy on two early-morning specimens | Treatment monitoring and follow-up | Smear microscopy has lower sensitivity than NAAT and does not detect drug resistance. It is now used mainly to assess treatment response, not for initial diagnosis [2]. |
| Tuberculin skin test (TST) read after 48–72 hours | Latent TB infection screening | TST indicates immune sensitization but cannot distinguish active pulmonary TB from prior BCG vaccination or latent infection. It is not a diagnostic test for active TB disease. |
| Chest X-ray alone, with sputum only if abnormal | Adjunct or triage tool | Chest X-ray is nonspecific and cannot confirm TB bacteriologically. Delaying sputum testing until after an abnormal film would miss smear-negative or minimal disease and delay treatment. |

Diagnostic performance considerations A prospective multicenter study evaluating a novel molecular assay reported an analytic limit of detection of 23.34 CFU/mL (95% CI 16.96–43.05) [1]. This level of sensitivity is substantially better than conventional smear microscopy, which typically requires 5,000–10,000 bacilli per mL of sputum for a positive result. The study compared the molecular assay against smear microscopy, culture, and Xpert MTB/RIF, reflecting the current standard of using culture as the reference comparator and molecular tests as the rapid front-line tool [1].

Programmatic and public health context The End TB Strategy targets a 90% reduction in TB incidence and a 95% reduction in TB mortality by 2035, and achieving these goals depends on point-of-care diagnostics that can be delivered at the most decentralized levels of care where patients first contact the health system . A rapid molecular test fits this requirement because it can be performed on an easily accessible sputum sample and provides results in a timely manner, enabling quick treatment turnaround . In an RHU setting, this means the nurse can arrange a NAAT on the same day the presumptive TB case is identified, rather than sending the client home to collect two early-morning sputum specimens over consecutive days.

Key point! The NTP algorithm for a presumptive TB case begins with a rapid molecular test (NAAT) on a single sputum specimen, not with smear microscopy or chest X-ray. Watch out! Do not confuse the role of smear microscopy: it remains valuable for monitoring treatment response, but it is no longer the preferred initial diagnostic test when NAAT is available. The simultaneous detection of TB and rifampicin resistance is the defining advantage that makes NAAT the first-choice test, because it directly informs both diagnosis and the selection of an effective treatment regimen from the outset.References (research sources)

- [1]Diagnostic accuracy of GeneReady MTB assay on sputum for detecting pulmonary tuberculosis: a prospective multicenter study in China.Research articleShang Y, Tang Z, Deng Y, Xu P, Ma Z, Shi J, Jing W, Xue J, Li S, Li L, Pang Y. (2026) · DOI: 10.1128/jcm.01713-25

- [2]Tuberculosis Diagnostics: State of the Art and Future DirectionsResearch articleMadhukar Pai, Mark Patrick Nicol, Catharina C. Boehme (2016) · DOI: 10.1128/microbiolspec.tbtb2-0019-2016

- [3]Current Landscape of Molecular Diagnostic Tests and Emerging Tools for Tuberculosis and Drug Resistance.Research articleEl Kassimi S, Eddabra R, Belkadi B, Filali-Maltouf A, Ait Benhassou H. (2026) · DOI: 10.3390/diagnostics16132133

## 임상 시나리오

NTP Initial Diagnostic Algorithm for Presumptive TBRapid molecular testing first in rural health settings
A client with cough of 2 weeks or more plus night sweats and weight loss meets the presumptive TB case definition. Arrange a rapid molecular test (NAAT) on a single sputum specimen as the initial diagnostic step.

The key advantage of NAAT platforms such as Xpert MTB/RIF is simultaneous detection of Mycobacterium tuberculosis and rifampicin resistance, allowing immediate initiation of an appropriate regimen without waiting for culture-based drug susceptibility testing.

Sputum smear microscopy is now reserved primarily for treatment monitoring, not initial diagnosis. Chest X-ray alone is insufficient for bacteriological confirmation.

CautionDo not delay treatment while awaiting results. If rifampicin resistance is detected, refer promptly for MDR-TB management. Ensure sputum collection follows infection control precautions.

## 핵심 개념

- **Presumptive TB** — A person with cough of 2 weeks or more plus at least one other symptom suggestive of TB, such as fever, night sweats, weight loss, or hemoptysis.
- **NAAT** — Nucleic acid amplification test that detects Mycobacterium tuberculosis DNA and can simultaneously identify rifampicin resistance markers.
- **Xpert MTB/RIF** — An automated cartridge-based NAAT platform recommended by WHO for decentralized, near-patient TB testing.
- **Rifampicin resistance** — A key indicator of multidrug-resistant TB (MDR-TB) that can be detected by rapid molecular testing.
- **Sputum smear microscopy** — A traditional TB diagnostic method now used primarily for monitoring treatment response rather than initial diagnosis.

## 같은 주제 문제

- [Situation: A public health nurse at a Rural Health Unit (RHU) in an agricultural municipal…](https://mymerci.kr/pages/nclex_q.php?qn_id=627012)
- [Situation: A public health nurse at a Rural Health Unit (RHU) manages clients enrolled in …](https://mymerci.kr/pages/nclex_q.php?qn_id=627024)
- [Situation: A public health nurse at a Rural Health Unit (RHU) manages clients enrolled in …](https://mymerci.kr/pages/nclex_q.php?qn_id=627025)
- [Situation: A public health nurse at a Rural Health Unit (RHU) manages clients enrolled in …](https://mymerci.kr/pages/nclex_q.php?qn_id=627026)
- [Situation: A public health nurse at a Rural Health Unit (RHU) manages clients enrolled in …](https://mymerci.kr/pages/nclex_q.php?qn_id=627027)
- [Situation: Dengue cases are being reported in a densely populated barangay during the rain…](https://mymerci.kr/pages/nclex_q.php?qn_id=627028)
- [Situation: Dengue cases are being reported in a densely populated barangay during the rain…](https://mymerci.kr/pages/nclex_q.php?qn_id=627029)
- [Situation: Dengue cases are being reported in a densely populated barangay during the rain…](https://mymerci.kr/pages/nclex_q.php?qn_id=627030)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._